article thumbnail

Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business

MedCity News

The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News. In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.

article thumbnail

Who Is Responsible for the High Cost of Prescription Drugs? One Advocate Weighs In

MedCity News

Multiple stakeholders are to blame for prescription drug costs, including pharmaceutical companies and PBMs, according to Merith Basey, executive director of Patients for Affordable Drugs. The post Who Is Responsible for the High Cost of Prescription Drugs? One Advocate Weighs In appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Social media and prescription drugs: A study

World of DTC Marketing

QUICK READ: A two-month analysis of social media and prescription drugs found the number one reason online health seekers use social media is to share and ask questions about medication side effects. ” – Patients were sharing experiences of switching to, or starting, prescription drugs.

Media 294
article thumbnail

Video: Besides, Pharma and PBMs, Who Drives Up Drug Costs?

MedCity News

If you thought that Big Pharma and the PBMs were the only bad guys in the saga of unreasonably high prescription drug prices in the United States, you would be wrong. The post Video: Besides, Pharma and PBMs, Who Drives Up Drug Costs? Hear who else is to blame from the CEO of Blue Shield of California.

Pharma 320
article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon. Pharma companies have very little control over patients’ prices for their Rxs. Let’s take a step back for a minute.

Insurance 226
article thumbnail

After protests, pharma industry reaches 'landmark' drug spending deal with UK government

Fierce Pharma

s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. s drug pricing policy, the pharma industry has secured an improved government spending deal. After blasting the U.K.’s After blasting the U.K.’s

article thumbnail

A Non-Profit Pharma Nabs FDA Nod for Non-Prescription Naloxone Nasal Spray

MedCity News

The FDA approved RiVive, an over-the-counter version of naloxone nasal spray from Harm Reduction Therapeutics. It’s the second such approval from the FDA this year, following an affirmative decision in March for OTC Narcan.

FDA 246